International Clinical Trial: A Prospective, Randomized Controlled Trial to Assess the Efficacy and Safety of Plasma-Activated Water (PAW) Produced by the Plasma Vaginal Irrigator (WOMEN CARE) for the Inhibition of Human Papillomavirus (HPV)

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (KCT0011358) titled 'A Prospective, Randomized Controlled Trial to Assess the Efficacy and Safety of Plasma-Activated Water (PAW) Produced by the Plasma Vaginal Irrigator (WOMEN CARE) for the Inhibition of Human Papillomavirus (HPV)' on Dec. 19, 2025.

Study Type: Interventional Study

Study Design: Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT

Primary Sponsor: Hanyang University Guri Hospital

Condition:

Certain infectious and parasitic diseases

Intervention: Medical Device, Procedure/Surgery : (1) Control Group - Follow-up from screening visit (Day 0) to assessment visits (2 a...